Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Amortizatization of Intangibles (2021 - 2023)

Envoy Medical recorded quarterly Amortizatization of Intangibles of $274633.0 in Q2 2023, up 17.1% quarter-over-quarter from $234525.0 in Q1 2023, and up 2208.34% year-over-year from $11897.4 in Q2 2022.

Envoy Medical's Amortizatization of Intangibles history runs 3 years deep, the most recent figure standing at $274633.0 for Q2 2023.

  • In Q2 2023, Amortizatization of Intangibles rose 2208.34% year-over-year to $274633.0; the TTM figure through Jun 2023 stood at $1.0 million (up 117.54% YoY), while the FY2022 annual figure was $704857.0, up 41.06% from the prior year.
  • Amortizatization of Intangibles came in at $274633.0 for Q2 2023 at Envoy Medical, up from $234525.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $520272.0 in Q4 2022 to a low of -$13026.0 in Q2 2022.
  • A 3-year average of $189434.1 and a median of $169773.0 in 2021 frame the typical range for Amortizatization of Intangibles.
  • Across the five-year window, Amortizatization of Intangibles sank 94.17% in 2022 and surged 2208.34% in 2023, its largest moves.
  • Envoy Medical's Amortizatization of Intangibles stood at $150729.0 in 2021, then surged by 245.17% to $520272.0 in 2022, then sank by 47.21% to $274633.0 in 2023.
  • According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $274633.0, $234525.0, and $520272.0 for Q2 2023, Q1 2023, and Q4 2022 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 422.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 180.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 6.50 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 75.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Envoy Medical 48.11 Mn 22.86 Mn -274,000.00 -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2023 274,633.00
Jun 30, 2023 274,633.00
Mar 31, 2023 234,525.00
Mar 31, 2023 234,525.00
Dec 31, 2022 520,272.00
Dec 31, 2022 520,272.00
Sep 30, 2022 8,794.00
Sep 30, 2022 8,794.00
Jun 30, 2022 -13,026.00
Jun 30, 2022 -13,026.00
Mar 31, 2022 188,817.00
Mar 31, 2022 188,817.00
Dec 31, 2021 150,729.00
Dec 31, 2021 150,729.00
Sep 30, 2021 150,729.00
Sep 30, 2021 150,729.00